In the above-mentioned article, Figure 3 contains a misalignment of the odds ratio of lipids in panels b--d. As a result, the correct odds ratios appeared in front of the wrong lipids. In the revised figure, the correct odds ratios are aligned with the correct lipids.Figure 3Odds ratio and 95% confidence interval of progression to end-stage kidney disease according to the FDR-proposed (top panel), RF-proposed (middle panel), and PLS-DA--proposed lipids (bottom panel) by change of each 1 SD in abundance of candidate lipids using (a) the logistic regression model in an unadjusted model, (b) adjusted models by eGFR and other factors (age, sex, race, diabetes, hypertension, and congestive heart failure), (c) adjusted models by the urine protein-to-creatinine ratio and other factors, and (d) adjusted models by eGFR, urine protein-to-creatinine ratio, and other factors in the training set. DAG, diacylglycerol; eGFR, estimated glomerular filtration rate; FDR, false discovery rate; MAG, monoacylglycerol; PC, phosphatidylcholine; PLS-DA, partial least square-discriminant analysis; RF, random forest.
